Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03536975
Other study ID # 2016/369/HP
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 1, 2017
Est. completion date December 31, 2018

Study information

Verified date May 2018
Source University Hospital, Rouen
Contact Isabelle Landrin
Phone 33 2 32 88 6523
Email isabelle.landrin@chu-rouen.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Our main goal is to test a web platform accessible by computers, smartphones and tablets, addressed specifically to caregivers and people with mild cognitive deterioration or mild to moderate dementia providing added value services based on social networks, adapted interventions, clinic strategies and gamification to improve the quality of life of caregivers and people living with dementia (dyads) and permitting to leave in the community as long as possible.

To evaluate the platform effectiveness and impact in dementia type disease affected people and caregivers a randomized, controlled, parallel, longitudinal is proposed. The objective will be to assess during 18 months aspects related to health of individuals (general aspect of health, neuropsychological, daily living functionalities, quality of life, treatment adherence, comorbidities ...), social aspects (improving dyad relationship…) and economics (cost-effectiveness of platform utilization), as well as satisfaction degree and usability of platform.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 31, 2018
Est. primary completion date December 31, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- For patients People, aged 50 and over, living in the community, who are able to give informed consent.

Diagnosed with mild cognitive impairment (MCI) according to Petersen criteria or mild to moderate dementia diagnosed according on DSM-IV criteria.

Having a Clinical Dementia Rating (CDR) of 0.5 for MCI, 1-2 for mild to moderate dementia Having a Mini-Mental Exam score (MMSE) between 30 and 25 (inclusive) for MCI, and between 24 and 10 (inclusive) for dementia.

Having a primary caregiver, familiar (or not), informal (or not) identified and also included in the study.

Be willing to use Information Technology and Communications (ICT) according to the investigator criteria.

Affiliated to the social security system.

- For caregivers People, aged 18 years and over, with no diagnosis or no evidence of mild cognitive impairment or mild to moderate dementia (according DSM-IV criteria), who are able to give informed consent and with an intention to complete the study.

Primary caregivers, informal (or not), familiar (or not), of person with mild cognitive impairment or mild to moderate dementia People with Internet access and basic knowledge and skills in managing internet and social networks, or keen to learn, according to the investigator criteria Having a Geriatric Depression Scale (GDS-Yesavage - 15 items) score less than 11 at the time of entry into the trial indicating no severe depressive symptoms or for people < 50 years a MADRS < 15 Having no specific conditions (evaluated by the investigator) reducing their physical abilities below the norm for their age that would limit or impair CAREGIVERSPRO-MMD platform use.

Be willing to use Information Technology and Communications (ICT) according to the investigator criteria Affiliated to the social security system

Exclusion Criteria:

- Terminal or severe illness with survival prognosis less than 18 months

- Not speaking nor reading French

- Enrolled in another clinical trial

- For the patients : Having delusions, hallucinations, behavioural disturbances, that may interfere with the use of Information and Communications Technology (ICT) tools ; Under guardianship and/or under curatorship

Study Design


Intervention

Other:
Platform
The groups will be comprised of one "intervention" group with access to the web platform "CAREGIVERSPRO-MMD" and another "control" group without any access to it

Locations

Country Name City State
France Centre Hospitalier Intercommunal Elbeuf Louviers Elbeuf
France Rouen University Hospital Rouen

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Rouen Centre Hospitalier Intercommunal Elbeuf-Louviers / Val de Reuil

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Burden of primary caregivers To evaluate the perceived burden of primary caregivers of persons living with mild cognitive impairment or mild to moderate dementia in order to identify a benefit from use of the CAREGIVERSPRO-MMD platform. The perceived burden will be evaluated by using a 29-item scale, Zarit Burden Interview (ZBI). 18 months
Secondary Quality of life of patients The 28-item DEMQoL (Dementia Quality of Life Proxy) assesses quality of life of people with mild to moderate dementia. It evaluates five domains: daily activities and locking after health and well-being, cognitive functioning, social relationships and self-concept. 6 months
Secondary Quality of life of patients The 28-item DEMQoL (Dementia Quality of Life Proxy) assesses quality of life of people with mild to moderate dementia. It evaluates five domains: daily activities and locking after health and well-being, cognitive functioning, social relationships and self-concept. 18 months
Secondary Quality of life of patients The 28-item DEMQoL (Dementia Quality of Life Proxy) assesses quality of life of people with mild to moderate dementia. It evaluates five domains: daily activities and locking after health and well-being, cognitive functioning, social relationships and self-concept. 12 months
Secondary Quality of life of caregivers The SF-36v2 - Medical Outcomes Study (MOS) 36-Item Short Form 2nd version will be used for caregivers. 6 months
Secondary Quality of life of caregivers The SF-36v2 - Medical Outcomes Study (MOS) 36-Item Short Form 2nd version will be used for caregivers. 12 months
Secondary Cognitive symptoms of patients Mini-Mental State Examination will be used to evaluate cognitive symptoms of patients with mild to moderate dementia. 18 months
Secondary Cognitive symptoms of patients Mini-Mental State Examination will be used to evaluate cognitive symptoms of patients with mild to moderate dementia. 6 months
Secondary Cognitive symptoms of patients Mini-Mental State Examination will be used to evaluate cognitive symptoms of patients with mild to moderate dementia. 12 months
Secondary Psychological symptoms of caregivers (1) Geriatric Depression Scale will be used to evaluate depression of older caregivers 6 months
Secondary Psychological symptoms of caregivers (1) Geriatric Depression Scale will be used to evaluate depression of older caregivers 12 months
Secondary Psychological symptoms of caregivers (1) Geriatric Depression Scale will be used to evaluate depression of older caregivers 18 months
Secondary Psychological symptoms of caregivers (2) State Trait Anxiety Inventory will be used to measure trait and state anxiety of caregivers 6 months
Secondary Psychological symptoms of caregivers (2) State Trait Anxiety Inventory will be used to measure trait and state anxiety of caregivers 12 months
Secondary Psychological symptoms of caregivers (2) State Trait Anxiety Inventory will be used to measure trait and state anxiety of caregivers 18 months
Secondary Instrumental Activities of Daily Living The ability to perform tasks necessary to live independently in the community will be assessed using Lawton Instrumental Activities of Daily Living Scale (IADL), (Lawton and Brody 1969) 6 months
Secondary Instrumental Activities of Daily Living The ability to perform tasks necessary to live independently in the community will be assessed using Lawton Instrumental Activities of Daily Living Scale (IADL), (Lawton and Brody 1969) 12 months
Secondary Instrumental Activities of Daily Living The ability to perform tasks necessary to live independently in the community will be assessed using Lawton Instrumental Activities of Daily Living Scale (IADL), (Lawton and Brody 1969) 18 months
Secondary Activities of Daily Living Performance in activity of daily living will be measured using Barthel Index of Activities of Daily Living scale (BADL) (Mahoney and Barthel 1965). 12 months
Secondary Activities of Daily Living Performance in activity of daily living will be measured using Barthel Index of Activities of Daily Living scale (BADL) (Mahoney and Barthel 1965). 18 months
Secondary Activities of Daily Living Performance in activity of daily living will be measured using Barthel Index of Activities of Daily Living scale (BADL) (Mahoney and Barthel 1965). 6 months
Secondary Behavioural-psychological symptoms of patients (1) Behavioural-psychological symptoms will be evaluated using NeuroPsychiatric Inventory (12-item NPI). The score takes into account the frequency and severity of each behavioural symptom. 6 months
Secondary Behavioural-psychological symptoms of patients (1) Behavioural-psychological symptoms will be evaluated using NeuroPsychiatric Inventory (12-item NPI). The score takes into account the frequency and severity of each behavioural symptom. 12 months
Secondary Behavioural-psychological symptoms of patients (1) Behavioural-psychological symptoms will be evaluated using NeuroPsychiatric Inventory (12-item NPI). The score takes into account the frequency and severity of each behavioural symptom. 18 months
Secondary Behavioural-psychological symptoms of patients (2) Geriatric Depression Scale 15 items evaluate depression of older people. A score above 11 is in favour of depression state. 18 months
Secondary Behavioural-psychological symptoms of patients (2) Geriatric Depression Scale 15 items evaluate depression of older people. A score above 11 is in favour of depression state. 6 months
Secondary Behavioural-psychological symptoms of patients (2) Geriatric Depression Scale 15 items evaluate depression of older people. A score above 11 is in favour of depression state. 12 months
Secondary Perceived Social Support Multidimensional Scale of Perceived Social Support (MSPSS) 12 items scale will be used to assess an individual's perception of the social support received from family, friends and significant others. Each item is quoted from 1(totally disagree) to 7 (totally agree). 6 months
Secondary Perceived Social Support Multidimensional Scale of Perceived Social Support (MSPSS) 12 items scale will be used to assess an individual's perception of the social support received from family, friends and significant others. Each item is quoted from 1(totally disagree) to 7 (totally agree). 12 months
Secondary Perceived Social Support Multidimensional Scale of Perceived Social Support (MSPSS) 12 items scale will be used to assess an individual's perception of the social support received from family, friends and significant others. Each item is quoted from 1(totally disagree) to 7 (totally agree). 18 months
Secondary Relationships The Flourishing Scale will be used to measure of the respondent's self-perceived success in important areas such as relationships, self-esteem, purpose and optimism. The scale provides a single psychological well-being score. It is a 8-item scale quoted from 1(totally disagree) to 7 (totally agree). 6 months
Secondary Relationships The Flourishing Scale will be used to measure of the respondent's self-perceived success in important areas such as relationships, self-esteem, purpose and optimism. The scale provides a single psychological well-being score. It is a 8-item scale quoted from 1(totally disagree) to 7 (totally agree). 12 months
Secondary Relationships The Flourishing Scale will be used to measure of the respondent's self-perceived success in important areas such as relationships, self-esteem, purpose and optimism. The scale provides a single psychological well-being score. It is a 8-item scale quoted from 1(totally disagree) to 7 (totally agree). 18 months
See also
  Status Clinical Trial Phase
Completed NCT04968041 - KNA Proof-of-Concept N/A
Recruiting NCT04262206 - Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults Phase 4
Active, not recruiting NCT04051918 - Robot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI) N/A
Completed NCT05544201 - Transcranial Alternating Current Stimulation (TACS) for Sleep Disturbances in Neurocognitive Disorders Due to Alzheimer's Disease N/A
Recruiting NCT03165396 - Appropriate Compatibility of Propofol and Sevoflurane for Orthopaedic Surgery of Patients With MCI N/A
Recruiting NCT05201534 - Interventions in Mathematics and Cognitive Skills N/A
Not yet recruiting NCT04863378 - Efficacy of a Multimodal Brain Health Intervention for Older African Americans N/A
Recruiting NCT06182995 - Anticipating Decline and Providing Therapy N/A
Recruiting NCT05200572 - Study of a Behavioral Intervention for Older Advanced Cancer Patients and Their Caregivers N/A
Completed NCT05892861 - The Effect of Multidomain Dietary Education in Type 2 Diabetic Adults N/A
Completed NCT04317612 - Effect of Nordic Berries on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiota in Adults With Mild Cognitive Impairment N/A
Completed NCT03653351 - Brain Stimulation and Enhancing Cognition in Older Adults N/A
Suspended NCT03755570 - How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
Completed NCT04440969 - Evaluation of Pilot Community-based Multi-domain Program Older Adults at Risk of Cognitive Impairment N/A
Completed NCT04200911 - Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway Early Phase 1
Recruiting NCT06192433 - Repeated Transcranial Magnetic Stimulation in the Elderly With Cognitive Impairment N/A
Recruiting NCT04032626 - MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients Phase 2
Completed NCT05922319 - Effects of Training Dose on Computerized Cognitive Training in Patients With Cognitive Impairment
Completed NCT03384043 - Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease N/A
Completed NCT04498195 - Walking on Cognitive Function in Individuals With Mild Cognitive Impairment: A Pilot Project N/A